Potential of artificial intelligence to accelerate diagnosis and drug discovery for COVID-19

Potential of artificial intelligence to accelerate diagnosis and drug discovery for COVID-19

The coronavirus disease (COVID-19) pandemic has caused havoc worldwide. The tests currently used to diagnose COVID-19 are based on real time reverse transcription polymerase chain reaction (RT-PCR), computed tomography medical imaging techniques and immunoassays. It takes 2 days to obtain results fr...

Full description

Bibliographic Details
Main Authors: Indira Mikkili, Abraham Peele Karlapudi, T. C. Venkateswarulu, Vidya Prabhakar Kodali, Deepika Sri Singh Macamdas, Krupanidhi Sreerama
Format: Article
Language:English
Published: PeerJ Inc. 2021-10-01
Series:PeerJ
Subjects:
Machine learning
Neural networks
Drug discovery
Reverse transcriptase polymerase chain reaction
Artificial intelligence
Computed tomography
Online Access:https://peerj.com/articles/12073.pdf

Similar Items

Similar Items